Switch to
More onapp

How to use scorecard? Learn more

Strides Pharma Science Ltd

STAR
Health CarePharmaceuticals
SmallcapWith a market cap of ₹9,092 cr, stock is ranked 555
Moderate RiskStock is 2.92x as volatile as Nifty
1,021.6032.40 (+3.28%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹9,092 cr, stock is ranked 555
Moderate RiskStock is 2.92x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
-128.73
PB RatioPB Ratio
4.18
Dividend YieldDiv. Yield
Sector PESector PE
46.01
Sector PBSector PB
6.09
Sector Div YldSctr Div Yld
0.55%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Strides Pharma Science is a vertically integrated global pharmaceutical company engaged in the development and manufacturing of active pharmaceutical ingredients and formulations, as well as biotech

Financial TrendFinancial statements 

20212022202320243.523.263.944.150.27-0.46-0.20-0.07
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 1.54%

High Pledged Promoter Holding
Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Loss/Duplicate-Share Certificate-XBRL 
Announced OnJul 23, 2024

STRIDES PHARMA SCIENCE LIMITED has informed the Exchange about Loss of share certificates | Download

STRIDES PHARMA SCIENCE LIMITED has informed the Exchange about Loss of share certificates | Download

Loss/Duplicate-Share Certificate-XBRL 
Announced OnJul 16, 2024

STRIDES PHARMA SCIENCE LIMITED has informed the Exchange about Loss of share certificates | Download

STRIDES PHARMA SCIENCE LIMITED has informed the Exchange about Loss of share certificates | Download

Cash Dividend 
Ex. DateAug 4, 2023

Final • Div/Share: ₹ 1.5

See all events